Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2023
Jan. 31, 2022
Income Statement [Abstract]        
Revenues $ 16,338 $ 34,046 $ 34,614 $ 60,565
Operating costs and expenses:        
Cost of revenues 15,079 17,838 29,750 33,111
Research and development 1,431 820 2,427 1,564
Selling, general and administrative 11,812 14,466 23,263 25,518
Legal and related expense, net 995 2,845 2,066 4,127
Total operating costs and expenses 29,317 35,969 57,506 64,320
Operating loss (12,979) (1,923) (22,892) (3,755)
Other income (expense):        
Interest, net 62 68 132 107
Other 125 (350) 130 (495)
Foreign exchange (loss) gain 1,472 (450) 675 (831)
Total other income (expense) 1,659 (732) 937 (1,219)
Loss before income taxes (11,320) (2,655) (21,955) (4,974)
Income taxes
Net loss $ (11,320) $ (2,655) $ (21,955) $ (4,974)
Net loss per common share:        
Basic and diluted (in Dollars per share) $ (0.23) $ (0.05) $ (0.45) $ (0.1)
Weighted average common shares outstanding:        
Basic and diluted (in Shares) 48,729 48,472 48,725 48,472